Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
everolimus serine/threonine-protein kinase mtor small molecule Successful target TTD , drugbank , DGIDB Subependymal Giant Cell Astrocytoma[MeSHID:D001254]
Pancreatic Neoplasm[MeSHID:D010190]
Tuberous Sclerosis[MeSHID:D014402]
treatment failure[MeSHID:D017211]
Renal Cell Carcinoma[MeSHID:D002292]
Operative Surgical Procedures[MeSHID:D013514]
Angiomyolipoma[MeSHID:D018207]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Kidney[MeSHID:D007668]
Malignant neoplasm of kidney[MeSHID:D007680]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.36 approved inhibitor
everolimus serine/threonine-protein kinase mtor small molecule Successful target TTD , drugbank , DGIDB Subependymal Giant Cell Astrocytoma[MeSHID:D001254]
Pancreatic Neoplasm[MeSHID:D010190]
Tuberous Sclerosis[MeSHID:D014402]
treatment failure[MeSHID:D017211]
Renal Cell Carcinoma[MeSHID:D002292]
Operative Surgical Procedures[MeSHID:D013514]
Angiomyolipoma[MeSHID:D018207]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Middle East Respiratory Syndrome[MeSHID:D018352]
Breast[MeSHID:D001940]		 0.36 approved inhibitor
click here to return to the previous page